Phibro Animal Health (PAHC) Income from Continuing Operations (2012 - 2026)

Phibro Animal Health (PAHC) recorded quarterly Income from Continuing Operations of 24024000.0 in Q1 2026, down 12.51% quarter-over-quarter from 27459000.0 in Q4 2025, and up 15.06% on a YoY basis from 20880000.0 in Q1 2025.

Phibro Animal Health (PAHC) Income from Continuing Operations (2012 - 2026) Analysis & Trends

Phibro Animal Health's Income from Continuing Operations history runs 15 years deep, the most recent figure standing at 24024000.0 for Q1 2026.

  • In Q1 2026, Income from Continuing Operations rose 15.06% year-over-year to 24024000.0; the TTM figure through Mar 2026 stood at 25792000.0 (up 1426.75% YoY), while the FY2025 annual figure was 21178000.0, up 32.38% from the prior year.
  • Income from Continuing Operations was 24024000.0 for Q1 2026 at Phibro Animal Health, down from 27459000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 27459000.0 in Q4 2025 to a low of 52218000.0 in Q2 2025.
  • Historically, Income from Continuing Operations has averaged 1405058.82 across 5 years, with a median of 6975000.0 in 2024.
  • The sharpest annual moves came in 2022 and 2025: Income from Continuing Operations sank 1747.96% in 2022, then soared 762.14% in 2025.
  • A 5-year view of Income from Continuing Operations shows it stood at 7210000.0 in 2022, then tumbled by 82.33% to 1274000.0 in 2023, then jumped by 150.0% to 3185000.0 in 2024, then soared by 762.14% to 27459000.0 in 2025, then fell by 12.51% to 24024000.0 in 2026.
  • The last three Income from Continuing Operations figures came in at 24024000.0 (Q1 2026), 27459000.0 (Q4 2025), and 26527000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 370.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 601.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 274.90 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 21.05 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 197.90 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 57.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -66.53 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -92.12 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 118.42 Mn
10 Phibro Animal Health 1.32 Bn 1.24 Bn 125.68 Mn 24.02 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 24.02 Mn
Dec 31, 2025 27.46 Mn
Sep 30, 2025 26.53 Mn
Jun 30, 2025 -52.22 Mn
Mar 31, 2025 20.88 Mn
Dec 31, 2024 3.19 Mn
Sep 30, 2024 6.98 Mn
Jun 30, 2024 -32.98 Mn
Mar 31, 2024 8.41 Mn
Dec 31, 2023 1.27 Mn
Sep 30, 2023 -8.02 Mn
Jun 30, 2023 -3.28 Mn
Mar 31, 2023 10.04 Mn
Dec 31, 2022 7.21 Mn
Sep 30, 2022 3.86 Mn
Jun 30, 2022 -37.15 Mn
Mar 31, 2022 17.69 Mn
Dec 31, 2021 17.47 Mn
Sep 30, 2021 6.53 Mn
Jun 30, 2021 2.25 Mn